Nitrofurantoin induced interstitial lung disease mimicking COVID-19 pneumonia: Case report and review of the literature

References (9)

1. Trusculescu AA, Manolescu D, Tudorache E, Oancea C. Deep learning in interstitial lung disease-how long until daily practice. Eur Radiol 2020; 30: 6285-92
2. Chen D, Jiang X, Hong Y, Wen Z, Wei S, Peng G, et al. Can chest CT features distinguish patients with negative from those with positive initial RT-PCR results for coronavirus disease (COVID-19)? AJR Am J Roentgenol 2020: 1-5
3. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiol 2020; 200642
4. Fisk AA. Anaphylactoid reaction to nitrofurantoin. N Engl J Med 1957; 256(22): 1054
5. Santos Seoane SM, Fernández-Madera-Martínez R, Taboada-Martínez ML. Reversible pulmonary toxicity by nitrofurantoin. Rev Clin Esp 2020; 220(1): 69-70
6. Mir E, Malik JA, Lone SA, Mohi-Ud-Din R, Khalil M. Spontaneous resolution of nitrofurantoin-induced chronic pulmonary toxicity presenting with respiratory failure. Adv Respir Med 2017; 85(6): 333-8
7. Koulaouzidis A, Bhat S, Moschos J, Tan C, De Ramon A. Nitrofurantoin-induced lung-and hepatotoxicity. Ann Hepatol 2007; 6(2): 119-21
8. Mendez JL, Nadrous HF, Hartman TE, Ryu JH. Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc 2005; 80(10): 1298-302
9. Sakata KK, Larsen BT, Boland JM, Palen B, Muhm Sr JR, Helmers RA, et al. Nitrofurantoin-induced granulomatous interstitial pneumonia. Int J Surg Pathol 2014; 22(4): 352- 7.